Skip to content

Target blood pressure intervention study in Chinese hypertensive patients with coronary heart disease

Target blood pressure intervention study in Chinese hypertensive patients with coronary heart disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034317
Enrollment
Unknown
Registered
2020-07-02
Start date
2020-07-01
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension, conoray heart disease

Interventions

Target BP 110-120mmHg:Nil
Target BP 120-130mmHg:Nil
Target BP 130-140mmHg:Nil

Sponsors

Chinese People's Liberation Army General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: After detailed inquiry of medical history, physical examination, electrocardiogram and myocardial enzymology, and coronary angiography confirmed that there is at least one main coronary artery lumen stenosis >= 50%, diagnosed with coronary heart disease and hypertension. The diagnostic criteria for hypertension are based on the 2018 Chinese Hypertension Prevention and Control Guidelines: Hypertension refers to systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg.

Exclusion criteria

Exclusion criteria: Aged < 18 years, pregnancy or lactation, malignant tumor, secondary hypertension, valvular heart disease, primary pulmonary hypertension, severe heart failure, severe liver and kidney dysfunction, metabolic diseases and rheumatic immune diseases.

Design outcomes

Primary

MeasureTime frame
Myocardial Infarction;Recurrent myocardial infarction;Stroke;all-cause death;

Countries

China

Contacts

Public ContactXue Hao

Chinese People's Liberation Army General Hospital

xuehao301@163.com+86 13811060426

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026